Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs03222315

Ligand	Ligand name	Chain	PDB	Tanimoto
CBW	(3BETA,5BETA,14BETA)-3-HYDROXY-11-OXOOLEAN-12-EN-29-OIC ACID	A	2W4Q	0.81
TES	TESTOSTERONE	A	1JTV	0.77
TES	TESTOSTERONE	A	2Q7L	0.77
TES	TESTOSTERONE	A	2Q7I	0.77
TES	TESTOSTERONE	A,B	1J96	0.77
TES	TESTOSTERONE	A	2Q7K	0.77
TES	TESTOSTERONE	A,B	1Q13	0.77
TES	TESTOSTERONE	H	1I9J	0.77
TES	TESTOSTERONE	A,B	1AFS	0.77
TES	TESTOSTERONE	H	1VPO	0.77
TES	TESTOSTERONE	A	2Q7J	0.77
TES	TESTOSTERONE	A,B	3BUR	0.77
TES	TESTOSTERONE	A	2AM9	0.77
R18	(17BETA)-17-HYDROXY-17-METHYLESTRA-4,9,11-TRIEN-3-ONE	A	1E3G	0.71
R18	(17BETA)-17-HYDROXY-17-METHYLESTRA-4,9,11-TRIEN-3-ONE	A,B	1E3K	0.71
R18	(17BETA)-17-HYDROXY-17-METHYLESTRA-4,9,11-TRIEN-3-ONE	A	2AO6	0.71
R18	(17BETA)-17-HYDROXY-17-METHYLESTRA-4,9,11-TRIEN-3-ONE	A	1XOW	0.71
R18	(17BETA)-17-HYDROXY-17-METHYLESTRA-4,9,11-TRIEN-3-ONE	A	1XQ3	0.71
PLO	(3BETA)-3-HYDROXYPREGN-5-EN-20-ONE	A	1Q20	0.71
0MA	maslinic acid	A	2QN2	0.72
0AS	asiatic acid	A	2QN1	0.74
NTH	SUCCINIC ACID MONO-(13-METHYL-3-OXO-2,3,6,7,8,9,10,11,12,13,14,15,16,17-TETRADECAHYDRO-1H-CYCLOPENTA[A]PHENANTHREN-17-YL) ESTER	A,B	1BUQ	0.7
1CA	DESOXYCORTICOSTERONE	A,B	1Y9R	0.76
1CA	DESOXYCORTICOSTERONE	A,B,C	2ABI	0.76
1CA	DESOXYCORTICOSTERONE	A	2Q3Y	0.76
1CA	DESOXYCORTICOSTERONE	A	2AA7	0.76
FFA	(10ALPHA,13ALPHA,14BETA,17ALPHA)-17-HYDROXYANDROST-4-EN-3-ONE	A,B	2IPG	0.77
FFA	(10ALPHA,13ALPHA,14BETA,17ALPHA)-17-HYDROXYANDROST-4-EN-3-ONE	A,B	2IPJ	0.77
FFA	(10ALPHA,13ALPHA,14BETA,17ALPHA)-17-HYDROXYANDROST-4-EN-3-ONE	A,B	2IPF	0.77
VTQ	RRR-ALPHA-TOCOPHERYLQUINONE	A,C,E	1OLM	0.75
CBO	CARBENOXOLONE	A,B,C,D	1HDC	0.76
CBO	CARBENOXOLONE	A,B,C,D	2BEL	0.76
C0R	CORTICOSTERONE	A	2A3I	0.72
C0R	CORTICOSTERONE	A,B	1Y5R	0.72
HCY	(11alpha,14beta)-11,17,21-trihydroxypregn-4-ene-3,20-dione	A,B	2VDY	0.7
HCY	(11alpha,14beta)-11,17,21-trihydroxypregn-4-ene-3,20-dione	A	2V95	0.7
DL4	(14beta,17alpha,25R)-3-oxocholest-4-en-26-oic acid	A	3GYT	0.76
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A,B	1E3R	0.72
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A	3DHE	0.72
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A	1J99	0.72
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A	1COY	0.72
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A	1Q22	0.72
17H	17-HYDROXY-18A-HOMO-19-NOR-17ALPHA-PREGNA-4,9,11-TRIEN-3-ONE	A	2AMB	0.71
DL7	(5beta,14beta,17alpha,25R)-3-oxocholest-7-en-26-oic acid	A	3GYU	0.72
PDN	17,21-DIHYDROXYPREGNA-1,4-DIENE-3,11,20-TRIONE	A	3EAU	0.7
PDN	17,21-DIHYDROXYPREGNA-1,4-DIENE-3,11,20-TRIONE	A	3EB3	0.7
PDN	17,21-DIHYDROXYPREGNA-1,4-DIENE-3,11,20-TRIONE	A	3EB4	0.7
PDN	17,21-DIHYDROXYPREGNA-1,4-DIENE-3,11,20-TRIONE	A,B	2AAX	0.7
PDN	17,21-DIHYDROXYPREGNA-1,4-DIENE-3,11,20-TRIONE	A	1H61	0.7
PDN	17,21-DIHYDROXYPREGNA-1,4-DIENE-3,11,20-TRIONE	A,B	3CMF	0.7
PDN	17,21-DIHYDROXYPREGNA-1,4-DIENE-3,11,20-TRIONE	A	2Q1V	0.7
NDR	(14beta,17alpha)-17-ethynyl-17-hydroxyestr-4-en-3-one	A,B	1SQN	0.76
NDR	(14beta,17alpha)-17-ethynyl-17-hydroxyestr-4-en-3-one	A,B	2W8Y	0.76
NOG	13-BETA-ETHYL-17-ALPHA-ETHYNYL-17-BETA-HYDROXYGON-4-EN-3-ONE	A	1LHV	0.76
NOG	13-BETA-ETHYL-17-ALPHA-ETHYNYL-17-BETA-HYDROXYGON-4-EN-3-ONE	A,B	3D90	0.76